Search Results - "Shoji, Masaaki"

Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments by Sase, Kazuhiro, Fujisaka, Yasuhito, Shoji, Masaaki, Mukai, Mikio

“…Opinion statement Lung cancer is the most common form of cancer in humans and the leading cause of cancer-related death worldwide. Traditionally, lung cancer…”
Get full text

Impact of Anemia on Clinical Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis Receiving Edoxaban　― Insights From the ONCO DVT Study by Fujiki, Shinya, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Umetsu, Michihisa, Nishimoto, Yuji, Takada, Takuma, Ogihara, Yoshito, Nishikawa, Tatsuya, Ikeda, Nobutaka, Otsui, Kazunori, Sueta, Daisuke, Tsubata, Yukari, Shoji, Masaaki, Shikama, Ayumi, Hosoi, Yutaka, Tanabe, Yasuhiro, Chatani, Ryuki, Tsukahara, Kengo, Nakanishi, Naohiko, Kim, Kitae, Ikeda, Satoshi, Kimura, Takeshi, Inomata, Takayuki, on behalf of the ONCO DVT Study Investigators

“…Background: The ONCO DVT study demonstrated potential benefits of extended edoxaban treatment in patients with isolated distal deep vein thrombosis in terms of…”
Get full text

Home Treatment for Active Cancer Patients With Low-Risk Pulmonary Embolism　― A Predetermined Companion Report From the ONCO PE Trial by Chatani, Ryuki, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Shioyama, Wataru, Shibata, Tatsuhiro, Nishimoto, Yuji, Ogihara, Yoshito, Doi, Kosuke, Oi, Maki, Shiga, Taro, Sueta, Daisuke, Kim, Kitae, Tanabe, Yasuhiro, Koitabashi, Norimichi, Takada, Takuma, Ikeda, Satoshi, Nakagawa, Hitoshi, Mitsuhashi, Takayuki, Shoji, Masaaki, Sakamoto, Jiro, Hisatake, Shinji, Ogino, Yutaka, Fujita, Masashi, Nakanishi, Naohiko, Dohke, Tomohiro, Hiramori, Seiichi, Nawada, Ryuzo, Kaneda, Kazuhisa, Mushiake, Kazunori, Yamamoto, Hiromi, Kadota, Kazushige, Ono, Koh, Kimura, Takeshi, on behalf of the ONCO PE Trial Investigators

“…Background: Patients with appropriately selected low-risk pulmonary embolism (PE) can be treated at home, although it has been controversial whether applies to…”
Get full text

Even Isolated Left Ventricular Hypertrabeculation May Indicate Multisystem Disease: Reply by Shoji, Masaaki

Get full text

Advantages and challenges for noninvasive atrial fibrillation ablation by Shoji, Masaaki, Inaba, Koji, Itami, Jun, Hamada, Minoru, Okamoto, Hiroyuki, Iwasa, Takeshi, Ushigusa, Takeshi, Yoshida, Masayuki, Matsuyama, Taka-aki, Otsuka, Takayuki, Kumagai, Koichiro, Hirao, Kenzo, Maguire, Patrick, Qian, Pierre, Gardner, Edward, Zei, Paul C.

“…Purpose Although catheter ablation is an effective therapy for atrial fibrillation (AF), risks remain and improved efficacy is desired. Stereotactic…”
Get full text

A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic by Shoji, Masaaki, Suzuki, Shinya, Otsuka, Takayuki, Arita, Takuto, Yagi, Naoharu, Semba, Hiroaki, Kano, Hiroto, Matsuno, Shunsuke, Kato, Yuko, Uejima, Tokuhisa, Oikawa, Yuji, Matsuhama, Minoru, Yajima, Junji, Yamashita, Takeshi

“…Objective The pharmacodynamic effect of warfarin varies among individuals, and its maintenance dose is widely distributed. Although many formulae for…”
Get full text

A Predictive Model for Cancer-Associated Thrombosis in Japanese Cancer Patients: Findings from the J-Khorana Registry by Shoji, Masaaki, Yamashita, Yugo, Ishii, Masanobu, Inoue, Hitoki, Kato, Hiroshi, Fujita, Shin, Matsui, Kazuhiro, Tajiri, Kazuko, Nameki, Mizuo, Muraoka, Nao, Nonaka, Akiko, Sugino, Hiroshi, Kono, Mihoko, Oka, Toru, Sueta, Daisuke, Komuro, Issei, Tsujita, Kenichi

“…Although the close relationship between cancer and venous thromboembolism (VTE) has been identified, risk stratification for VTE in Japanese patients with…”
Get full text

Fabrication of IoT Force Sensor Module in Five-day Program for Students as Part of Nanotechnology Platform Japan Project by Totsu, Kentaro, Moriyama, Masaaki, Watanabe, Hiraku, Kikuta, Toshiyuki, Hemmi, Masahiro, Shoji, Masaaki, Yoshida, Takashi, Tatsuta, Masataka

“…An IoT force sensor module was fabricated and demonstrated in a five-day practical program for students, as part of the Nanotechnology Platform Japan project…”
Get full text

Electrocardiography Characteristics of Isolated Non-Compaction of Ventricular Myocardium in Japanese Adult Patients by Shoji, Masaaki, Yamashita, Takeshi, Uejima, Tokuhisa, Asada, Kazuo, Semba, Hiroaki, Otsuka, Takayuki, Sagara, Koichi, Sawada, Hitoshi, Isobe, Mitsuaki, Aizawa, Tadanori

“…Background: Isolated non-compaction of ventricular myocardium (INVM) is characterized by persistent embryonic myocardial morphology without other cardiac…”
Get full text

Improvement in karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid by Matsuura, Tomokazu, Wakino, Shu, Yoshifuji, Ayumi, Nakamura, Toshifumi, Tokuyama, Hirobumi, Hashiguchi, Akinori, Konishi, Konosuke, Iwasa, Takeshi, Shoji, Masaaki, Hosono, Ako, Ohashi, Ken, Chuman, Hirokazu, Itoh, Hiroshi

“…Long-term nephrotoxicity of ifosfamide is occasionally progressive, and, in such case, there has been no specific treatment to prevent progression. It has been…”
Get full text

Arrhythmia by Shoji, Masaaki, Yamashita, Takeshi

Get more information

Dynamic narrowing of left ventricular outflow tract—Possible mechanism of latent left ventricular outflow tract obstruction by Shoji, Masaaki, MD, Uejima, Tokuhisa, MD, Matsuno, Shunsuke, MD, Oikawa, Yuji, MD, Yajima, Junji, MD, Yamashita, Takeshi, MD, FJCC, Koike, Akira, MD, FJCC, Sawada, Hitoshi, MD, FJCC, Isobe, Mitsuaki, MD, FJCC, Aizawa, Tadanori, MD, FJCC

“…Summary It has been reported that left ventricular outflow tract (LVOT) obstruction can be provoked in patients even without significant left ventricular…”
Get full text

Prospective Registry of Rivaroxaban Management of Cancer-Associated Venous Throboembolism (PRIMECAST) Study by Tamura, Yuichi, Iwasa, Takeshi, Kumamaru, Hiraku, Miyata, Hiroaki, Mukai, Mikio, Shigematsu, Kunihiro, Shoji, Masaaki, Tanabe, Nobuhiro, Yamada, Norikazu, Yasuda, Chikao, Miyata, Tetsuro

“…Background:The incidence of thromboembolism in patients with cancer is approximately 11%, and the risk of thrombosis in patients with malignant tumors is…”
Get full text

Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis (ONCO DVT Study): An Open-Label, Multicenter, Randomized Clinical Trial by Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Oyakawa, Takuya, Umetsu, Michihisa, Akamatsu, Daijirou, Nishimoto, Yuji, Sato, Yukihito, Takada, Takuma, Jujo, Kentaro, Minami, Yuichiro, Ogihara, Yoshito, Dohi, Kaoru, Fujita, Masashi, Nishikawa, Tatsuya, Ikeda, Nobutaka, Hashimoto, Go, Otsui, Kazunori, Mori, Kenta, Sueta, Daisuke, Tsubata, Yukari, Shoji, Masaaki, Shikama, Ayumi, Hosoi, Yutaka, Tanabe, Yasuhiro, Chatani, Ryuki, Tsukahara, Kengo, Nakanishi, Naohiko, Kim, Kitae, Ikeda, Satoshi, Mo, Makoto, Yoshikawa, Yusuke, Kimura, Takeshi

“…The optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer is clinically relevant, but the evidence is…”
Get full text

Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial) by Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Shioyama, Wataru, Chatani, Ryuki, Shibata, Tatsuhiro, Nishimoto, Yuji, Ogihara, Yoshito, Doi, Kosuke, Oi, Maki, Shiga, Taro, Sueta, Daisuke, Kim, Kitae, Tanabe, Yasuhiro, Koitabashi, Norimichi, Takada, Takuma, Ikeda, Satoshi, Nakagawa, Hitoshi, Tsukahara, Kengo, Shoji, Masaaki, Sakamoto, Jiro, Hisatake, Shinji, Ogino, Yutaka, Fujita, Masashi, Nakanishi, Naohiko, Dohke, Tomohiro, Hiramori, Seiichi, Nawada, Ryuzo, Kaneda, Kazuhisa, Ono, Koh, Kimura, Takeshi

“…Background: The optimal duration of anticoagulation therapy for patients with cancer and acute low-risk pulmonary embolism (PE) is clinically relevant, but…”
Get full text

Different murine-derived feeder cells alter the definitive endoderm differentiation of human induced pluripotent stem cells by Shoji, Masaki, Minato, Hiroki, Ogaki, Soichiro, Seki, Masahide, Suzuki, Yutaka, Kume, Shoen, Kuzuhara, Takashi

“…The crosstalk between cells is important for differentiation of cells. Murine-derived feeder cells, SNL76/7 feeder cells (SNLs) or mouse primary embryonic…”
Get full text

Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT Study by Xiong, Wei, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Umetsu, Michihisa, Nishimoto, Yuji, Takada, Takuma, Ogihara, Yoshito, Nishikawa, Tatsuya, Ikeda, Nobutaka, Otsui, Kazunori, Sueta, Daisuke, Tsubata, Yukari, Shoji, Masaaki, Shikama, Ayumi, Hosoi, Yutaka, Tanabe, Yasuhiro, Chatani, Ryuki, Tsukahara, Kengo, Nakanishi, Naohiko, Kim, Kitae, Ikeda, Satoshi, Ono, Koh, Kimura, Takeshi

“…The ONCO DVT study (Edoxaban for 12 Months Versus 3 Months in Patients With Cancer With Isolated Distal Deep Vein Thrombosis) revealed superiority of 12-month…”
Get full text

The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT study by Sueta, Daisuke, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Umetsu, Michihisa, Nishimoto, Yuji, Takada, Takuma, Ogihara, Yoshito, Nishikawa, Tatsuya, Ikeda, Nobutaka, Otsui, Kazunori, Tsubata, Yukari, Shoji, Masaaki, Shikama, Ayumi, Hosoi, Yutaka, Tanabe, Yasuhiro, Chatani, Ryuki, Tsukahara, Kengo, Nakanishi, Naohiko, Kim, Kitae, Ikeda, Satoshi, Mo, Makoto, Kimura, Takeshi, Tsujita, Kenichi

“…The multicenter, open-label, randomized clinical trial ONCO DVT compared 3-month and 12-month edoxaban treatment regimens for isolated distal deep vein…”
Get full text

A Simple Formula for Predicting the Maintenance Dose of Warfarin with Reference to the Initial Response to Low Dosing at an Outpatient Clinic by Shoji, Masaaki, Suzuki, Shinya, Otsuka, Takayuki, Arita, Takuto, Yagi, Naoharu, Semba, Hiroaki, Kano, Hiroto, Matsuno, Shunsuke, Kato, Yuko, Uejima, Tokuhisa, Oikawa, Yuji, Matsuhama, Minoru, Yajima, Junji, Yamashita, Takeshi

“…Objective The pharmacodynamic effect of warfarin varies among individuals, and its maintenance dose is widely distributed. Although many formulae for…”
Get full text

Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study by Chatani, Ryuki, Yamashita, Yugo, Morimoto, Takeshi, Muraoka, Nao, Umetsu, Michihisa, Nishimoto, Yuji, Takada, Takuma, Ogihara, Yoshito, Nishikawa, Tatsuya, Ikeda, Nobutaka, Otsui, Kazunori, Sueta, Daisuke, Tsubata, Yukari, Shoji, Masaaki, Shikama, Ayumi, Hosoi, Yutaka, Tanabe, Yasuhiro, Tsukahara, Kengo, Nakanishi, Naohiko, Kim, Kitae, Ikeda, Satoshi, Mushiake, Kazunori, Kadota, Kazushige, Ono, Koh, Kimura, Takeshi

“…Abstract Background The ONCO DVT study revealed the superiority of 12-month relative to 3-month edoxaban treatment for cancer-associated isolated distal deep…”
Get full text